Cediranib
- Generic Name
- Cediranib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H27FN4O3
- CAS Number
- 288383-20-0
- Unique Ingredient Identifier
- NQU9IPY4K9
- Background
The novel indole-ether quinazoline Cediranib is a highly potent (IC < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro. It is being developed clinically as a once-daily oral therapy for the treatment of cancer.
- Indication
For the treatment of liver cancer, advanced non-small cell lung cancer (NSCLC), advanced colorectal cancer (CRC) and other solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath